Home About The Publisher

About The Publisher


In January 1972, young Peter Nwangwu came to the United States for his
college education at the University of Nebraska at Lincoln. He placed out of
many courses by challenge exams, and was elected into the university’s honor
roll beginning from his first year, and also into the national scholastic honor
society, Phi Eta Sigma, the exclusive academic honorary for selected men in
American universities.

Nwangwu was an extremely focused and intelligent
student. He made history at Nebraska when he became the first student to earn a
Bachelor’s degree from the University of Nebraska after two years of
undergraduate studies. He earned a master’s degree from the department of
Medicinal Chemistry and Pharmacognosy and the Department of
Pharmacodynamics and Toxicology in 1976.

His doctoral training at the
University of Nebraska Medical Center was in interdisciplinary medical
sciences, with special focus on Pharmacology, which he pursued together with
the professional doctor of pharmacy degree.

He made even more history when
he became the first student at the university to earn the Pharm.D. and Ph.D.
degrees simultaneously. He has advanced training, degree, and productive
research experience in every area of pharmacy. He was the third person in the
United States to earn the Pharm. D., Ph. D. degree, only behind Gerald E.
Schumacher who served as Dean of Pharmacy at Northeastern University in the
late 1970’s/80’s and Harry Rosenberg who currently serves as President at
Roseman University of Health Sciences, Nevada (formerly the University of
Southern Nevada).

He accepted a position as Director of Clinical Research and Assistant Professor
of Pharmacology and Toxicology at Florida A & M University in 1979. In 1981
he was appointed Associate Professor of Pharmacology and Toxicology at St.
John’s University in New York. He joined the world headquarters of
multibillion dollar multinational drug manufacturing company, Ayerst
Laboratories, in Manhattan New York as Clinical Research Monitor in 1983.

He started the first pharmaceutical manufacturing company owned by a black man
in the United States, and served on the board of directors of several companies
in the U.S. He has been nominated three different times by his professional
peers as candidate to serve as President of three universities in the United
States: University of Wisconsin-Eau Claire, Alabama A & M University, and
Albany State University, Albany, Georgia, all in 2005.

From 2006 to 2011, he served as Executive Assistant to the President (Vice Chancellor) at the University of Nigeria (over 40,000 students and 2000 academic staff) and full
Professor of Pharmacology, Toxicology, and Clinical Pharmacy. He worked
with and reported directly to the President and was a key member of the
President’s administrative cabinet. He assisted the President, and collaborated
with senior University leadership including deans, and Directors, to guide the
school in implementing and advancing the strategic plans of the University.

In addition, Nwangwu served simultaneously as the Chief Development Officer of
the University, and also as the President and CEO of the University of Nigeria
Research and Economic Development (UNRED) Foundation, Inc.
In a historical reference book, “The Nigerian-Americans”, published in America
by Greenwood Press, authored by Professor Ogbaa, Peter Nwangwu, along with
Haakeem Olajuwon and Phillip Emeagwali were among the twelve Nigerian-
born Americans in American History who were selected and documented as
Nigerian-born Americans who have made the greatest positive impact and
contributions to the American society.

He is an outstanding and very
accomplished pharmacist, medical scientist, inventor, educator, and
entrepreneur. Specific examples of meritorious research productivity, and
significant inventions in the field of Medicine, Pharmacy, and Pharmaceutical
Research and Development by Professor Nwangwu include:
 Invented a new technique for screening antiarrhythmic drugs which
received worldwide acceptance and became popular worldwide; the
technique is still used in several pharmaceutical companies and
pharmacology laboratories as a standard screening technique for
antiarrhythmic drugs, “A rapid in vivo Technique for Preliminary
screening of Antiarrhythmic Agents in Mice” Arch. Int. Pharmacodyn
Therap. 229, 219 (1977).

He Developed and characterized seven new antiarrhythmic drugs which are
protected by U.S. patents. Relevant research publications in major world
scientific literature by Professor Nwangwu on the discovery of these
seven new drugs include: J. Pharm. Pharmacol 46, 301 (1979);
Toxicology 16, 73 (1980); Current Therapeutic Research 29: 416 (1981);
J. Cardiovasc Pharmacol 4, 124 (1982); Current Therapeutic Research 30,
479 (1981); J. Med. Chem. 22, 110 (1979).
He Invented a new technique for identification of time of Myocardial
Infarction Employing TC-99 pyrophosphate, Current Therapeutic
Research 30: 122 (1981).

He Documented and published the first in vivo murine ventricular
tachycardia in a single surface electrocardiogram lead, which has become
a relevant murine model of human cardiomyopathy for significant studies
in cardiovascular disease worldwide.

As the first Medical Scientist in the
world to discover and publish in vivo murine ventricular tachycardia in a
single surface electrocardiogram lead, Professor Nwangwu is widely
quoted by Medical Scientists worldwide who employ his original
research technique and breakthrough as a murine model of human
cardiomyopathy for studies in cardiovascular disease worldwide,
including scientists at Harvard medical school.

In a recent article by scientists in peer reviewed European journal, Turkish
Journal of Politics, Vol. 2, No. 2, p. 81, winter 2011, the scientists cited
Nwangwu by name as, “…a world renowned clinical Pharmacologist who ranks
among the top ten Pharmacologists in the world.”

Nwangwu has over 30 years of experience in pharmaceutical research and
development, including 15 years as President, CEO, and Chairman of the Board
of pharmaceutical manufacturing companies in the United States, Punlabs
Quality Products, Inc. and Ebony Pharmaceutical Manufacturing, Inc.

He has
very strong food and drug regulatory experience, including serving for many
years as a member of the technical and drug regulatory committee of the
National Pharmaceutical Alliance, Washington, D.C. He has extensive
experience with United States Food and Drug Administration. His book,
“Concepts and Strategies in New Drug Development,” is used in
pharmaceutical industries worldwide, and as a textbook in some Clinical
Pharmacology graduate training programs in U.S. universities.

The publisher of
the book, Praeger Publishers, New York, described it as their best seller in New
Drug Development in the United States, Canada, and Europe. Nwangwu has
served on the editorial board of four different reputable International Journals in
pharmaceutical research.

He is a potent fund raiser, and has extensive
experience and the necessary contacts for securing research grants; his research
has been funded significantly by the U.S. National Institute of Health (NIH). He
still serves as Member of the prestigious U.S. scientific and technology think-
tank group of experts, “The Council of Healthcare and Biotechnology
Advisors,” Gerson Lehrman Group, New York, New York, which is a select
group of distinguished scientific and technical professionals carefully assembled
by the Wall Street investment advisory firm, Gerson Lehrman Group, to provide
paid healthcare and biotechnology market research, industry recommendations,
and consulting services worldwide.

Nwangwu has extensive experience in new
drug development, and Clinical Trials of New Drugs. He is distinguished,
credible and reputable because of his inventions and books which are used
In addition to these, Professor Nwangwu is a devout priest of the Anglican
Church, with a deep and reverent fear of God. He practices his belief and faith;
therefore, he is utterly dependable and honorable. His life is impeccable and
above reproach. He also served as the Associate Chaplain of Christ Church
Chapel, the large multi-denominational Church of Anglicans, Methodists,
Presbyterians, and other Protestant denominations at the University of Nigeria.

Nwangwu has received many awards and honors, including being listed in more
than twenty biographical reference books. In September 2006, Nwangwu was
honored in the United States as the recipient of “The 2006 Congressional Medal
of Distinction”. In 2005, he was decorated with three meritorious awards; he
was named the recipient of “The 2005 President Ronald Reagan Republican.

Gold Medal”, by the National Republican Congressional Committee,
Washington D.C.; he was named “Man of the Year 2005”, by the American
Biographical Institute, Raleigh North Carolina; and he was also named
“Businessman of the Year 2005”, by the United States Business Advisory
Council, Washington, D.C. He received a letter from United States
Congressman Tom Reynolds inviting him to dinner with President Bush in
Washington D.C. to celebrate his awards, which took place on March 16, 2006.
In May, 2008, his alma mater in the United States selected Nwangwu as “The
2008 Outstanding International Alumnus of the University of Nebraska”.

Only one person in the world is selected for this award. Nwangwu was the second
person to receive the award from when it was established at the University.
Nwangwu took all members of his family including his parents to the United
States. Nwangwu is a great lover and mentor of young people, Nigerian youths,
and has taken 76 young Nigerians for their University education in the United
States. At least 40 out of the 76 now have their PhD degrees in various fields.
He was elected unanimously as the Presidential candidate for the African
Democratic Congress (ADC) political party and ran for President of Nigeria in
the 2011 Nigerian Presidential elections.
Peter is married to Patience, and they have five sons and one daughter.